A detailed history of Public Employees Retirement Association Of Colorado transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Public Employees Retirement Association Of Colorado holds 428,473 shares of VRTX stock, worth $201 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
428,473
Previous 428,720 0.06%
Holding current value
$201 Million
Previous $201 Million 0.83%
% of portfolio
0.79%
Previous 0.84%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $113,620 - $124,927
-247 Reduced 0.06%
428,473 $199 Million
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $417,164 - $515,632
-1,062 Reduced 0.25%
428,720 $201 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $2.08 Million - $2.27 Million
-5,092 Reduced 1.17%
429,782 $180 Million
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $466,823 - $558,935
-1,361 Reduced 0.31%
434,874 $177 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $141 Million - $151 Million
417,906 Added 2280.03%
436,235 $152 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $145 Million - $156 Million
-429,224 Reduced 95.9%
18,329 $65,000
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $190,852 - $213,609
-607 Reduced 0.14%
447,553 $157 Million
Q1 2023

May 08, 2023

SELL
$283.23 - $323.1 $483,756 - $551,854
-1,708 Reduced 0.38%
448,160 $141 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $814,416 - $916,218
-2,850 Reduced 0.63%
449,868 $130 Million
Q3 2022

Nov 15, 2022

BUY
$273.83 - $305.53 $591,746 - $660,250
2,161 Added 0.48%
452,718 $131 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $99,153 - $123,456
-422 Reduced 0.09%
450,557 $127 Million
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $2.54 Million - $3 Million
-11,482 Reduced 2.48%
450,979 $118 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $1.18 Million - $1.49 Million
-6,646 Reduced 1.42%
462,461 $102 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $1.04 Million - $1.16 Million
-5,716 Reduced 1.2%
469,107 $85.1 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $6.21 Million - $7.32 Million
-33,126 Reduced 6.52%
474,823 $95.7 Million
Q1 2021

May 13, 2021

SELL
$207.02 - $241.31 $7.91 Million - $9.22 Million
-38,207 Reduced 7.0%
507,949 $109 Million
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $23.9 Million - $31.9 Million
-115,572 Reduced 17.47%
546,156 $129 Million
Q3 2020

Nov 09, 2020

SELL
$255.65 - $303.1 $3.89 Million - $4.62 Million
-15,226 Reduced 2.25%
661,728 $180 Million
Q2 2020

Aug 05, 2020

SELL
$225.48 - $295.8 $76,888 - $100,867
-341 Reduced 0.05%
676,954 $197 Million
Q1 2020

May 01, 2020

SELL
$199.77 - $247.81 $1.79 Million - $2.22 Million
-8,963 Reduced 1.31%
677,295 $161 Million
Q4 2019

Feb 05, 2020

SELL
$166.71 - $223.91 $219,723 - $295,113
-1,318 Reduced 0.19%
686,258 $150 Million
Q3 2019

Nov 05, 2019

SELL
$166.23 - $187.09 $126,334 - $142,188
-760 Reduced 0.11%
687,576 $116 Million
Q2 2019

Jul 31, 2019

BUY
$164.61 - $190.37 $31.9 Million - $36.9 Million
193,602 Added 39.13%
688,336 $126 Million
Q1 2019

Apr 30, 2019

BUY
$163.73 - $194.7 $363,808 - $432,623
2,222 Added 0.45%
494,734 $91 Million
Q4 2018

Feb 08, 2019

SELL
$151.91 - $192.21 $16,406 - $20,758
-108 Reduced 0.02%
492,512 $81.6 Million
Q3 2018

Oct 29, 2018

SELL
$167.73 - $192.74 $8,051 - $9,251
-48 Reduced 0.01%
492,620 $94.9 Million
Q2 2018

Aug 02, 2018

SELL
$145.72 - $169.96 $724,082 - $844,531
-4,969 Reduced 1.0%
492,668 $83.7 Million
Q1 2018

May 01, 2018

SELL
$151.6 - $177.13 $1.18 Million - $1.38 Million
-7,804 Reduced 1.54%
497,637 $81.1 Million
Q4 2017

Feb 02, 2018

BUY
$137.28 - $155.55 $7 Million - $7.93 Million
50,973 Added 11.22%
505,441 $75.7 Million
Q3 2017

Oct 30, 2017

BUY
$148.13 - $162.24 $67.3 Million - $73.7 Million
454,468
454,468 $69.1 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.